Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;13(4):197-206.
doi: 10.1159/000279621. Epub 2010 Apr 15.

Structuring public engagement for effective input in policy development on human tissue biobanking

Affiliations

Structuring public engagement for effective input in policy development on human tissue biobanking

Kieran C O'Doherty et al. Public Health Genomics. 2010.

Abstract

We begin with the premise that human tissue biobanking is associated with ethical ambiguities and regulatory uncertainty, and that public engagement is at least one important element in addressing such challenges. One is then confronted with how to achieve public engagement that is both meaningful and effective. In particular, how can public engagement on the topic of biobanking be implemented so that (a) it is perceived broadly as legitimate and (b) the results of the engagement are relevant and useful to the institutional and regulatory context? In this paper we build on previous work that has addressed the former point and focus primarily on the latter. We argue that one way to increase the likelihood of results of public engagement being taken up in policy is through framing the issues that are deliberated by members of the public based in part on the practical policy questions for which input is sought. In this approach, we move discussion on the social and ethical implications of biobanking from abstract principles, to their consideration in the context of local biobanking practices. This is illustrated using a practical example involving a public engagement conducted to inform institutional policy for biobanking in British Columbia, Canada.

PubMed Disclaimer

References

    1. Burgess M, O’Doherty K, Secko D. Biobanking in BC: Enhancing discussions of the future of personalized medicine through deliberative public engagement. Personalized Medicine. 2008;5:285–296. - PubMed
    1. O’Doherty KC, Burgess MM. Engaging the public on biobanks: Outcomes of the BC Biobank Deliberation. Public Health Genomics. 2009;12:203–215. - PubMed
    1. Brand AM, Probst-Hensch NM. Biobanking for epidemiological research and public health. Pathobiology. 2007;74:227–238. - PubMed
    1. Swen JJ, Huizinga TW, Gelderblom H, et al. Translating Pharmacogenomics: Challenges on the Road to the Clinic. PLoS Medicine. 2007;4:1317–1324. - PMC - PubMed
    1. Avard D, Bucci LM, Burgess M, Kaye J, Heeney C, Cambon-Thomsen A. Public Health Genomics (PHG) and Public Participation: Point to Consider. Journal of Public Deliberation. 2009;5:7.

Publication types

Grants and funding